Registered Trials
-
NCT05037188
Phase 1/2Russian Federation
Total Enrollment: 160
Official Trial Registration:
© 2022 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.